ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc (0LB2)

55.00
0.00
( 0.00% )
Updated: 19:00:00

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 302.24M408.9M392.76M520.4M586.31M667.75M609.04M667.93M
Operating Income 99.54M144.44M148.57M173.7M86.03M46.12M-5.27M81.67M
Pre Tax Income 100.62M140.18M147.49M168.65M73.18M60.74M2.77M97.87M
Net Income 57.28M110.99M113.06M126.95M53.42M60.71M1.32M73.87M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 1.1162.1222.1522.4011.0031.1190.0241.338
EBIT 99.25M144.44M148.57M173.7M86.03M46.12M-5.27M81.67M
EBITDA 107.64M151.54M155.23M193.7M118.62M131.67M99.78M162.04M

Your Recent History

Delayed Upgrade Clock